Renaissance Technologies LLC Reduces Holdings in Oscar Health, Inc. (NYSE:OSCR)

Renaissance Technologies LLC decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 24.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,677,673 shares of the company's stock after selling 886,427 shares during the period. Renaissance Technologies LLC owned 1.08% of Oscar Health worth $35,988,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State Street Corp raised its position in Oscar Health by 6.0% in the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after buying an additional 291,335 shares during the last quarter. Lingotto Investment Management LLP bought a new position in Oscar Health during the fourth quarter valued at approximately $2,543,000. GDS Wealth Management grew its position in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock worth $4,648,000 after purchasing an additional 324,798 shares during the period. Victory Capital Management Inc. raised its stake in Oscar Health by 296.0% during the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock valued at $3,105,000 after buying an additional 172,706 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Oscar Health in the 4th quarter worth $5,672,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $20.21.

Oscar Health Stock Down 1.8 %

Shares of Oscar Health stock traded down $0.23 during trading on Thursday, reaching $12.13. The company's stock had a trading volume of 950,135 shares, compared to its average volume of 3,858,810. Oscar Health, Inc. has a 1-year low of $11.47 and a 1-year high of $23.79. The company has a 50-day simple moving average of $13.86 and a two-hundred day simple moving average of $15.22. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.04 billion, a price-to-earnings ratio of -604.95 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, equities analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.